As we watch tennis unfold in 2024, it's hard not to think about the players who've been sidelined due to doping suspensions. Some cases are clear-cut, while others involve contaminated supplements or substances like SARMs - S-22 and Ligandrol - that blur the lines. Take the recent instances involving top tennis players, for example. Their stories serve as a cautionary tale about the risks of unregulated supplements and the importance of strict testing. It's a complex issue that challenges the integrity of the sport, leaving fans and officials alike to wonder about the true cost of winning.